Randy Berholtz

This profile gathers the share dealings of Randy Berholtz across 2 companies, led by Innovus Pharmaceuticals, Inc. and Seelos Therapeutics, Inc. We count 5 filings; the first trade dates from 11 August 2011 and the latest from 22 November 2017.

On the market, this insider has only ever bought: 4 purchases, €1,389 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. So far in 2017, the count stands at 4 purchases and no sales.

In size, the median ticket on the buying side is €408. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 27 November 2017, reports an open-market purchase of €412 in Innovus Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.